116 related articles for article (PubMed ID: 1672154)
41. [Malignant salivary gland tumors. Effect of histology and site on prognosis].
Chilla R; Casjens R; Eysholdt U; Droese M
HNO; 1983 Aug; 31(8):286-90. PubMed ID: 6629867
[TBL] [Abstract][Full Text] [Related]
42. Tumour growth fraction and apoptosis in salivary gland acinic cell carcinomas. Prognostic implications of Ki-67 and bcl-2 expression and of in situ end labelling (TUNEL).
Hellquist HB; Sundelin K; Di Bacco A; Tytor M; Manzotti M; Viale G
J Pathol; 1997 Mar; 181(3):323-9. PubMed ID: 9155720
[TBL] [Abstract][Full Text] [Related]
43. Squamous cell carcinomas, an immunohistochemical and ultrastructural study.
Suo Z; Holm R; Nesland JM
Anticancer Res; 1992; 12(6B):2025-31. PubMed ID: 1284199
[TBL] [Abstract][Full Text] [Related]
44. Rare expression of the c-erbB-2 oncoprotein in salivary gland tumors: an immunohistochemical study.
Shrestha P; Huang JW; Tsuji T; Shinozaki F; Maeda K; Sasaki K; Ueno K; Yamada K; Mori M
J Oral Pathol Med; 1992 Nov; 21(10):477-80. PubMed ID: 1361005
[TBL] [Abstract][Full Text] [Related]
45. Production and characterization of a polyclonal antibody to the c-erbB-3 protein: examination of c-erbB-3 protein expression in adenocarcinomas.
Poller DN; Spendlove I; Baker C; Church R; Ellis IO; Plowman GD; Mayer RJ
J Pathol; 1992 Nov; 168(3):275-80. PubMed ID: 1361526
[TBL] [Abstract][Full Text] [Related]
46. [Evaluation of immunoreactivity to erbB-2 protein as a marker of prognosis in bile duct carcinoma].
Motojima K; Komuta K; Hiasa A; Tsuribune T; Hashimoto T; Tsunoda T; Kanematsu T
Nihon Geka Gakkai Zasshi; 1992 Sep; 93(9):952-5. PubMed ID: 1361658
[TBL] [Abstract][Full Text] [Related]
47. Basal membrane associated substances in human salivary glands and salivary gland tumours.
Caselitz J; Schmitt P; Seifert G; Wustrow J; Schuppan D
Pathol Res Pract; 1988 Aug; 183(4):386-94. PubMed ID: 2847123
[TBL] [Abstract][Full Text] [Related]
48. Immunoexpression of c-erbB-2 and p53 in benign and malignant salivary neoplasms with myoepithelial differentiation.
Rosa JC; Félix A; Fonseca I; Soares J
J Clin Pathol; 1997 Aug; 50(8):661-3. PubMed ID: 9301549
[TBL] [Abstract][Full Text] [Related]
49. Immunoreactive prolactin in lesions and tumours of salivary glands.
Ninomiya T; Orito T; Tsukitani K; Mori M; Imanishi Y
Acta Histochem; 1988; 84(1):41-50. PubMed ID: 3146854
[TBL] [Abstract][Full Text] [Related]
50. Analysis of c-erbB-2 amplification in salivary gland tumours by differential polymerase chain reaction.
Birek C; Lui E; Jordan RC; Dardick I
Eur J Cancer B Oral Oncol; 1994 Jan; 30B(1):47-50. PubMed ID: 9135973
[TBL] [Abstract][Full Text] [Related]
51. Demonstration of c-erbB-2 oncogene overexpression in salivary gland neoplasms by in situ hybridization.
Jordan R; Dardick I; Lui E; Birek C
J Oral Pathol Med; 1994 May; 23(5):226-31. PubMed ID: 7913972
[TBL] [Abstract][Full Text] [Related]
52. Differential expression of topoisomerase IIalpha protein in salivary gland carcinomas: histogenetic and prognostic implications.
Maruya S; Shirasaki T; Nagaki T; Kakehata S; Kurotaki H; Mizukami H; Shinkawa H
BMC Cancer; 2009 Feb; 9():72. PubMed ID: 19250538
[TBL] [Abstract][Full Text] [Related]
53. Apoptosis is inversely related to bcl-2 but not to bax expression in salivary gland tumours.
Soini Y; Törmänen U; Pääkkö P
Histopathology; 1998 Jan; 32(1):28-34. PubMed ID: 9522213
[TBL] [Abstract][Full Text] [Related]
54. Immunohistochemical evaluation with Ki-67: an application to salivary gland tumours.
Murakami M; Ohtani I; Hojo H; Wakasa H
J Laryngol Otol; 1992 Jan; 106(1):35-8. PubMed ID: 1371801
[TBL] [Abstract][Full Text] [Related]
55. Immunopathological study of neuropeptide expression in human salivary gland neoplasms.
Hayashi Y; Deguchi H; Nakahata A; Kurashima C; Hirokawa K
Pathobiology; 1990; 58(4):212-20. PubMed ID: 1701303
[TBL] [Abstract][Full Text] [Related]
56. Immunohistochemical study of androgen, estrogen and progesterone receptors in salivary gland tumors.
Ito FA; Ito K; Coletta RD; Vargas PA; Lopes MA
Braz Oral Res; 2009; 23(4):393-8. PubMed ID: 20027446
[TBL] [Abstract][Full Text] [Related]
57. Amylase as an additional marker of salivary gland neoplasms. An immunoperoxidase study.
Caselitz J; Seifert G; Grenner G; Schmidtberger R
Pathol Res Pract; 1983 Mar; 176(2-4):276-83. PubMed ID: 6190154
[TBL] [Abstract][Full Text] [Related]
58. Immunohistochemical evaluation of transglutaminase C in tumours of salivary glands.
Lee CH; Lee SK; Chi JG; Park SC; Chung SI; Saitoh M; Shrestha P; Mori M
Eur J Cancer B Oral Oncol; 1996 Nov; 32B(6):401-6. PubMed ID: 9039224
[TBL] [Abstract][Full Text] [Related]
59. S-100 protein in salivary gland tumors: an immunohistochemical study of 129 cases.
Zarbo RJ; Regezi JA; Batsakis JG
Head Neck Surg; 1986; 8(4):268-75. PubMed ID: 3017896
[TBL] [Abstract][Full Text] [Related]
60. Genetic expression profiling of parotid neoplasms by cDNA microarrays.
Pastore A; Carinci F; Pelucchi S
Acta Otorhinolaryngol Ital; 2005 Jun; 25(3):153-60. PubMed ID: 16450770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
